Healthcare provider profile · identity verified

Adam D Gardner, MD

Family Practice · OKLAHOMA CITY, OK · NPI 1689093288

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	262	87
Amlodipine Besylate	Amlodipine Besylate	219	72
Levothyroxine Sodium	Levothyroxine Sodium	212	71
Lisinopril	Lisinopril	207	63
Hydrochlorothiazide	Hydrochlorothiazide	180	57
Rosuvastatin Calcium	Rosuvastatin Calcium	164	62
Losartan Potassium	Losartan Potassium	161	52
Gabapentin	Gabapentin	153	45
Ozempic	Semaglutide	133	27
Metformin Hcl	Metformin Hcl	130	40
Omeprazole	Omeprazole	117	35
Pantoprazole Sodium	Pantoprazole Sodium	115	47
Metoprolol Succinate	Metoprolol Succinate	105	33
Zolpidem Tartrate	Zolpidem Tartrate	103	16
Pregabalin	Pregabalin	98	22
Tamsulosin Hcl	Tamsulosin Hcl	92	29
Tramadol Hcl	Tramadol Hcl	92	28
Albuterol Sulfate Hfa	Albuterol Sulfate	90	32
Mounjaro	Tirzepatide	84	17
Tizanidine Hcl	Tizanidine Hcl	83	27
Trazodone Hcl	Trazodone Hcl	82	22
Furosemide	Furosemide	81	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	73	29
Meloxicam	Meloxicam	69	19
Duloxetine Hcl	Duloxetine Hcl	68	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	65	18
Fluticasone Propionate	Fluticasone Propionate	64	24
Jardiance	Empagliflozin	63	15
Montelukast Sodium	Montelukast Sodium	63	24
Allopurinol	Allopurinol	60	23
Pravastatin Sodium	Pravastatin Sodium	60	22
Potassium Chloride	Potassium Chloride	59	21
Carvedilol	Carvedilol	57	17
Celecoxib	Celecoxib	54	22
Bupropion Xl	Bupropion Hcl	53	17
Simvastatin	Simvastatin	52	16
Eliquis	Apixaban	51	14
Glimepiride	Glimepiride	49	18
Metformin Hcl Er	Metformin Hcl	48	15
Alprazolam	Alprazolam	47	17
Azithromycin	Azithromycin	45	33
Triamcinolone Acetonide	Triamcinolone Acetonide	44	20
Escitalopram Oxalate	Escitalopram Oxalate	38	11
Ezetimibe	Ezetimibe	37	12
Lorazepam	Lorazepam	36	suppressed
Eszopiclone	Eszopiclone	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Methylprednisolone	Methylprednisolone	34	28
Metoprolol Tartrate	Metoprolol Tartrate	34	12
Fluoxetine Hcl	Fluoxetine Hcl	33	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	suppressed
Baclofen	Baclofen	32	suppressed
Ondansetron Odt	Ondansetron	32	21
Finasteride	Finasteride	31	11
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	13
Prednisone	Prednisone	29	12
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Ibuprofen	Ibuprofen	28	suppressed
Nystatin	Nystatin	28	suppressed
Atenolol	Atenolol	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Sertraline Hcl	Sertraline Hcl	26	11
Alendronate Sodium	Alendronate Sodium	25	suppressed
Clonazepam	Clonazepam	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Glipizide	Glipizide	24	suppressed
Spironolactone	Spironolactone	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	15
Memantine Hcl	Memantine Hcl	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	16
Irbesartan	Irbesartan	19	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Varenicline Tartrate	Varenicline Tartrate	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Famotidine	Famotidine	18	suppressed
Fluconazole	Fluconazole	18	14
Novolog Flexpen	Insulin Aspart	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	15
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	14
Propranolol Hcl	Propranolol Hcl	17	suppressed
Cephalexin	Cephalexin	16	13
Januvia	Sitagliptin Phosphate	16	suppressed
Liothyronine Sodium	Liothyronine Sodium	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Amoxicillin	Amoxicillin	15	12
Clonidine Hcl	Clonidine Hcl	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Estradiol	Estradiol	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	11
Lamotrigine	Lamotrigine	12	suppressed
Cefdinir	Cefdinir	11	suppressed
Colchicine	Colchicine	11	suppressed
Diazepam	Diazepam	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Naproxen	Naproxen	11	suppressed
Temazepam	Temazepam	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error